These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 311616

  • 1. Comparative inhibition beta-lactamases by novel beta-lactam compounds.
    Fu KP, Neu HC.
    Antimicrob Agents Chemother; 1979 Feb; 15(2):171-6. PubMed ID: 311616
    [Abstract] [Full Text] [Related]

  • 2. Clavulanic acid, a novel inhibitor of beta-lactamases.
    Neu HC, Fu KP.
    Antimicrob Agents Chemother; 1978 Nov; 14(5):650-5. PubMed ID: 310279
    [Abstract] [Full Text] [Related]

  • 3. CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization.
    English AR, Retsema JA, Girard AE, Lynch JE, Barth WE.
    Antimicrob Agents Chemother; 1978 Sep; 14(3):414-9. PubMed ID: 309306
    [Abstract] [Full Text] [Related]

  • 4. A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor.
    Aswapokee N, Neu HC.
    J Antibiot (Tokyo); 1978 Dec; 31(12):1238-44. PubMed ID: 310815
    [Abstract] [Full Text] [Related]

  • 5. Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases.
    Neu HC.
    Am J Med; 1985 Nov 29; 79(5B):2-12. PubMed ID: 3907341
    [Abstract] [Full Text] [Related]

  • 6. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.
    Reading C, Cole M.
    Antimicrob Agents Chemother; 1977 May 29; 11(5):852-7. PubMed ID: 879738
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM, Ueno Y, Cunha BA.
    Chemotherapy; 1996 May 29; 42(5):334-42. PubMed ID: 8874972
    [Abstract] [Full Text] [Related]

  • 8. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E.
    Acta Med Croatica; 2004 May 29; 58(4):307-12. PubMed ID: 15700687
    [Abstract] [Full Text] [Related]

  • 9. Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains.
    Matsuura M, Nakazawa H, Hashimoto T, Mitsuhashi S.
    Antimicrob Agents Chemother; 1980 Jun 29; 17(6):908-11. PubMed ID: 6967713
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics.
    Kobayashi F, Saino Y, Koshi T, Hattori Y, Nakayama M, Iwasaki A, Mori T, Mitsuhashi S.
    Antimicrob Agents Chemother; 1982 Apr 29; 21(4):536-44. PubMed ID: 6979308
    [Abstract] [Full Text] [Related]

  • 11. Synergistic activity of piperacillin in combination with beta-lactamase inhibitors.
    Neu HC, Fu KP.
    Antimicrob Agents Chemother; 1980 Oct 29; 18(4):582-5. PubMed ID: 6255862
    [Abstract] [Full Text] [Related]

  • 12. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ, Jin YF, Turner HL.
    J Antimicrob Chemother; 1993 Jan 29; 31(1):89-103. PubMed ID: 8383105
    [Abstract] [Full Text] [Related]

  • 13. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor.
    Coleman K, Griffin DR, Page JW, Upshon PA.
    Antimicrob Agents Chemother; 1989 Sep 29; 33(9):1580-7. PubMed ID: 2817854
    [Abstract] [Full Text] [Related]

  • 14. In-vitro evaluation of ampicillin/brobactam and comparison with other beta-lactam antibiotics.
    Melchior NH, Keiding J.
    J Antimicrob Chemother; 1991 Jan 29; 27(1):29-40. PubMed ID: 1646779
    [Abstract] [Full Text] [Related]

  • 15. Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.
    Moosdeen F, Keeble J, Williams JD.
    Rev Infect Dis; 1986 Jan 29; 8 Suppl 5():S562-8. PubMed ID: 3026004
    [Abstract] [Full Text] [Related]

  • 16. In-vitro activity and beta-lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343.
    Neu HC, Chin NX, Labthavikul P.
    J Antimicrob Chemother; 1985 Jun 29; 15 Suppl C():25-37. PubMed ID: 3875603
    [Abstract] [Full Text] [Related]

  • 17. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH, Chan KC, Liu HB, Chung WH, Leung YC, Wong KY.
    Anal Chem; 2005 Aug 15; 77(16):5268-76. PubMed ID: 16097768
    [Abstract] [Full Text] [Related]

  • 18. 'Beta-lactams' as beta-lactamase inhibitors.
    Cole M.
    Philos Trans R Soc Lond B Biol Sci; 1980 May 16; 289(1036):207-23. PubMed ID: 6109317
    [Abstract] [Full Text] [Related]

  • 19. Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.
    Rotschafer JC, Ostergaard BE.
    Am J Health Syst Pharm; 1995 Mar 15; 52(6 Suppl 2):S15-22. PubMed ID: 7606585
    [Abstract] [Full Text] [Related]

  • 20. The inhibition of staphylococcal beta-lactamase by clavulanic acid.
    Reading C, Hepburn P.
    Biochem J; 1979 Apr 01; 179(1):67-76. PubMed ID: 38773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.